At eight years old, I had my third open-heart surgery — this time, to “tune up” my Fontan and implant my first pacemaker.

Nobu Bangkok is on everyone’s hit list for the superlative Peruvian-Japanese menu (black cod and butter lettuce or Wagyu ...

Amid a slew of secondary equity raisings and at least two planned IPOs, the biotech sector is ending a difficult year on a ...

Rubedo Life Sciences, Inc. (Rubedo), a leading AI-driven, clinical-stage biotech specializing in selective cellular rejuvenation medicines, today announced a strategic partnership with SVAX during the ...

Correcting And Replacing Wave Life Sciences Announced Positive Target Engagement Data From INLIGHT Clinical Trial Of WVE-007 For Obesity During Annual Research Day. This press release corrects and ...

Recorded $51.7 million in net product sales of YUTREPIA™ as launch momentum continuesAchieved profitability in the first full quarter of YUTREPIA ...

Good morning. Welcome to today's conference call to discuss Kimberly-Clark's acquisition of Kenvue. [Operator Instructions]. With that, I would now like to turn the call over to Chris Jakubik, ...

Q3 2025 Earnings Call Transcript October 28, 2025 Regeneron Pharmaceuticals, Inc. beats earnings expectations. Reported EPS ...

The Society for Immunotherapy of Cancer (SITC) received an incredible number of abstract submissions in 2025, more than 1,300, including many clinical based Late-breaking Abstracts. SITC is proud to ...

Discusses Innovations in Inhaled Treprostinil Therapies and Updates on Drug Delivery Technologies October 28, 2025 2:00 ...

Cost of service revenue was $0.9 million for the three months ended September 30 ... maintain or improve functional class, delay disease progression and improve quality of life. About Pulmonary ...